Nephrology & urology
Kidney & urinary clinical trials
Kidney disease and conditions of the bladder and urinary tract. We’re tracking 4,387 recruiting studies in this area right now.
By phase
- Not applicable2,710
- Phase 2569
- Phase 1367
- Phase 3266
- Phase 1/Phase 2227
- Phase 4192
- Phase 2/Phase 356
Top conditions
- Prostate Cancer645
- Bladder Cancer186
- Acute Kidney Injury133
- Chronic Kidney Diseases123
- Chronic Kidney Disease107
- Breast Cancer105
- Renal Cell Carcinoma80
- Urinary Incontinence60
- Kidney Cancer59
- Colorectal Cancer58
- Ovarian Cancer57
- Lung Cancer51
- Cancer48
- Lupus Nephritis48
- Melanoma48
- Metastatic Prostate Cancer47
- Head and Neck Cancer46
- Prostate Cancer (Adenocarcinoma)45
Leading sponsors
- Mayo Clinic64
- National Cancer Institute (NCI)48
- Peking University First Hospital39
- M.D. Anderson Cancer Center36
- Novartis Pharmaceuticals34
- Chinese University of Hong Kong33
- AstraZeneca29
- IRCCS Azienda Ospedaliero-Universitaria di Bologna29
- Memorial Sloan Kettering Cancer Center29
- Assistance Publique - Hôpitaux de Paris27
Where studies are running
- California359
- Arizona109
- Alabama107
- Florida95
- New York95
- Maryland91
- Texas91
- Massachusetts89
- Illinois66
- Minnesota50
Recruiting studies4,387 total
- NCT06205576Recruiting
Balloon treatment for narrowed AV fistula veins
This trial tests a balloon device to open up narrowed veins in an AV fistula used for dialysis. It may help if your fistula has a blockage that causes problems like high pressure or low blood flow.
BeijingAges 18–85 - NCT06058078RecruitingPhase 2
Cell therapy for active lupus nephritis
This trial tests a new cell therapy (RY_SW01) for people with active lupus nephritis (kidney inflammation caused by lupus) who haven't responded well to standard treatments. It aims to see if the therapy can help control the disease.
Nanjing, JiangsuAges 18–65 - NCT06211790RecruitingPhase 2
Targeted first-line treatment for advanced kidney cancer based on protein profile
This trial tests a first-line precision treatment for clear cell kidney cancer that has spread or cannot be removed. It aims to match the treatment to your cancer's protein profile to improve outcomes.
ShanghaiAges 18–75 - NCT05452291Recruiting
Testing multi-sample biomarkers for recurring kidney stones
This study looks for “biomarkers,” which are measurable signs in samples like urine or blood, to help understand and detect recurring urinary stone disease. It may help future patients by improving how doctors predict stone recurrence or identify stone types.
ShatinAges 18 years+ - NCT06219746Recruiting
New imaging scan for high-risk prostate cancer staging
This trial tests a special type of scan (99mTc-MIP-1404 SPECT/CT) to see how well it can detect the spread of high-risk prostate cancer. It may help doctors better understand the stage of the disease before deciding on treatment.
Turku, Southwest FinlandAges 18 years+ - NCT06225882Recruiting
Follow-up study for patients with primary hyperoxaluria type 1 on Lumasiran
This study follows patients with primary hyperoxaluria type 1 who are being treated with Lumasiran. It aims to understand how well the treatment works over time.
BesançonAges birth–99 years - NCT03414827Recruiting
Genetic testing study for kidney cancer
This study looks at genetic features of kidney cancer by testing tumor samples. The goal is to find biomarkers—specific signs—that may help predict what kind of kidney cancer it is.
RoskildeAges Any age - NCT03962920Recruiting
Personalized care for urologic cancer based on gut and urine bacteria
This study looks at how your body’s bacteria (microbiome in and around the urinary/genital area) may help guide personalized treatment for localized urologic cancers. The goal is to see whether tailoring treatment to your bacteria could improve outcomes.
RoskildeAges 40–70 - NCT05060783Recruiting
Liquid blood test to help detect kidney cancer
This study tests whether a “liquid biopsy” blood test can help detect kidney cancer when a CT scan looks suspicious but does not show cancer. It may help avoid unnecessary procedures or catch cancer patterns earlier, but it will depend on the type of kidney tumor and your situation.
RoskildeAges 18 years+ - NCT03857373Recruiting
Study testing a computer tool to detect kidney cancer after surgery
This trial is for people with renal (kidney) cancer who have already had surgery. The study is testing whether a computer method can use medical information from you to improve kidney-cancer detection.
RoskildeAges Any age - NCT04064671Recruiting
Study of a specific erectile implant after sex reassignment surgery
This study looks at surgical outcomes after placing the Zephyr ZSI 475 FTM inflatable penile implant in people who had female-to-male (transmasculine) sex reassignment surgery. It may help improve how well this specific implant works and how patients do after surgery.
Ghent, Oost-VlaanderenAges 18–100 - NCT03225586Recruiting
Study of health differences in urban and rural communities
This study enrolls consenting adults to understand how health differs between people living in cities versus rural areas. Your participation may help researchers learn what factors influence health over time.
Rosario, Santa Fe ProvinceAges 35–70 - NCT05971537RecruitingPhase 4
Antibiotic lock treatment for repeat peritonitis in catheter patients
This trial studies using an “antibiotic lock” inside a Tenckhoff catheter to prevent relapsing or repeat peritonitis in people on peritoneal dialysis. It may help stop infections that come back soon after antibiotics, especially when the same germ is causing them.
Tai PoAges 18 years+ - NCT06239909Recruiting
Adjustable sphincter for urine leakage after prostate surgery
This trial is testing an adjustable artificial sphincter called Victo to help men who leak urine after prostate surgery. It may improve bladder control and quality of life.
Ostrava, Moravian-Silesian RegionAges 18 years+ - NCT06236789Recruiting
Ifosfamide for men with advanced prostate cancer
This trial is studying whether the chemotherapy drug ifosfamide (given with mesna to protect the bladder) can help men whose prostate cancer has spread and is no longer controlled by hormone therapy. It is for men who have already tried the chemotherapy docetaxel.
SeoulAges 19 years+ - NCT05952947RecruitingPhase 1
Study drug for HPV18-positive solid tumors with a specific immune marker
This Phase 1 trial tests HRYZ-T101 injection for people whose solid cancer is HPV18-positive and who have the HLA-DRB1*0901 immune marker. It is meant for people whose cancer has returned or spread and who have few or no effective treatment options.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07859436Recruiting
Audio consent for kidney stone surgery
This study tests whether adding a voice recording (human or AI) to the written consent form helps patients understand their upcoming kidney stone surgery better before they agree to it.
Aydin, AydınAges 18 years+ - NCT05531240Recruiting
Comparing two procedures for an enlarged prostate
This study compares two common procedures for treating an enlarged prostate, a condition where the prostate grows and blocks urine flow. One procedure removes part of the prostate through the urethra, while the other blocks the blood supply to shrink it.
Helsingborg, Region SkånesAges 45 years+ - NCT07860047RecruitingPhase 2
Peptide vaccine with antibody therapy for prostate cancer
This trial tests a combination of a personalized peptide vaccine and an antibody therapy for men with prostate cancer that has returned after initial treatment. The goal is to see if this approach can control the cancer without needing stronger hormone therapy.
Heidelberg, Baden-WurttembergAges 18–80 - NCT06220188RecruitingPhase 2
PSMA therapy for prostate cancer that has come back
This trial tests a targeted radiation therapy (PSMA-RLT) for men whose prostate cancer has returned after initial treatment, shown only by rising PSA levels. It aims to control the cancer without using hormone therapy.
ViennaAges 18–80 - NCT06259760Recruiting
Kidney risk after low-blood-pressure anesthesia for jaw surgery
This study looks at factors that may increase the risk of kidney injury during jaw surgery when a special low-blood-pressure anesthesia technique is used. It helps doctors understand who is more likely to have complications.
Kaohsiung City, Sanmin DistAges 18–65 - NCT06259123RecruitingPhase 2
PSMA Radiotherapy Before Prostate Cancer Surgery
This trial tests a radioactive drug (PSMA-RLT) given before surgery for prostate cancer that has spread to a few spots. It aims to see if this treatment can stop the cancer from growing further.
ViennaAges 18–75 - NCT06260579Recruiting
Home exercise program after kidney transplant
This study tests whether a home exercise program, especially with higher intensity, can help people recover better after a kidney transplant. You would exercise on a stationary bike at home, with guidance from a team.
GhentAges 18 years+ - NCT07856199Recruiting
Checking pelvic arteries in men with heart disease
This study uses a special ultrasound probe during heart catheterization to look at the arteries in the pelvis that supply the penis. It aims to see if plaque buildup in these arteries is linked to erectile dysfunction in men who have heart disease.
Mexico City, Mexico CityAges 18 years+
Common questions
- How many kidney & urinary clinical trials are recruiting?
- Clin2 is tracking 4,387 recruiting nephrology & urology studies from the U.S. registry right now, out of 6,805 we cover in this area in total.
- What does “Kidney & urinary” cover here?
- Kidney disease and conditions of the bladder and urinary tract. We group each study into kidney & urinary based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a kidney & urinary trial near me?
- Use the search to filter kidney & urinary studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.